Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Photochemically Induced Collagen Cross-Linking in Unstable Corneas
NCT02095730Phase 3Unknown
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of riboflavin in keratoconus and corneal ectasia (4 arms). Primary endpoint: Visual Acuity at 2 years. Status: unknown.
02
Drugs
riboflavin
03
Conditions
keratoconuscorneal ectasia
Beyond the preview
Go deeper on NCT02095730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095730.